-
Indirect Costs Associated With Neovascular Age-Related Macular Degeneration (nAMD) in Colombia
Mar 10, 2025, 14:00 PM -
Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic
Mar 10, 2025, 14:00 PM -
Retrospective Databases in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research
Mar 10, 2025, 14:00 PM -
An Economic Model Exploring the Impact of Formulary Restrictions on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants in the United States
Mar 10, 2025, 14:00 PM -
Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey
Mar 10, 2025, 14:00 PM -
Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia
Mar 10, 2025, 14:00 PM -
A Retrospective Analysis of the Italian Medicines Agency’s Evaluation of Real-World Evidence in Innovativeness Assessments
Mar 10, 2025, 14:00 PM -
Conceptual Framework for a De Novo Cost-effectiveness Model in Glycogen Storage Disease Type Ia (GSDIa)
Mar 10, 2025, 14:00 PM -
Assessing VYVGART Social Media Data in Generalized Myasthenia Gravis To Understand Patient, Caregiver, and HCP Sentiment
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)
Mar 10, 2025, 14:00 PM -
Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC
Mar 10, 2025, 14:00 PM -
Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population
Mar 10, 2025, 14:00 PM -
Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments
Mar 10, 2025, 14:00 PM -
Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
The Global Economic Burden of Type 1 Diabetes: Current Estimates and Projections to 2040
Mar 10, 2025, 14:00 PM -
Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data
Mar 10, 2025, 14:00 PM -
Risk of Hospital Readmission Among Adults Aged 50 Years and Older Hospitalized With Respiratory Syncytial Virus (RSV) or Influenza
Mar 10, 2025, 14:00 PM -
The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland
Mar 10, 2025, 14:00 PM
